发明名称 SPIRO-OXINDOLE COMPOUND AND ITS USE AS THERAPEUTIC AGENT
摘要 <P>PROBLEM TO BE SOLVED: To provide compounds which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions. <P>SOLUTION: The invention relates to spiro-oxindole compounds represented by formula (I) (wherein, k, j, Q, R<SP POS="POST">1</SP>, R<SP POS="POST">2a</SP>, R<SP POS="POST">2b</SP>, R<SP POS="POST">2c</SP>, R<SP POS="POST">2d</SP>, R<SP POS="POST">3a</SP>, R<SP POS="POST">3b</SP>, R<SP POS="POST">3c</SP>, and R<SP POS="POST">3d</SP>are as defined in the specification) as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. Pharmaceutical compositions comprising the compounds and methods of preparing and using the compounds are also disclosed. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2012246313(A) 申请公布日期 2012.12.13
申请号 JP20120201716 申请日期 2012.09.13
申请人 XENON PHARMACEUTICALS INC 发明人 CHAFEEV MIKHAIL;CHOWDHURY SULTAN;FRASER ROBERT;FU JIANMIN;KAMBOJ RAJENDER;HOU DUANJIE;LIU SHIFENG;BAGHERZADEH MEHRAN SEID;SVIRIDOV SERGUEI;SUN SHAOYI;SUN JIANYU;CHAKKA NAGASREE;HSIEH TOM;RAINA VANDNA
分类号 C07D491/107;A61K31/407;A61K31/4184;A61K31/4192;A61K31/422;A61K31/4245;A61K31/428;A61K31/433;A61K31/4439;A61K31/454;A61K31/4545;A61K31/4709;A61K31/506;A61K31/5377;A61P3/10;A61P5/14;A61P9/06;A61P9/10;A61P19/02;A61P21/00;A61P21/02;A61P21/04;A61P25/00;A61P25/02;A61P25/04;A61P25/08;A61P25/22;A61P25/28;A61P29/00;A61P35/00;A61P43/00;C07D491/113;C07D491/20;C07D513/20 主分类号 C07D491/107
代理机构 代理人
主权项
地址